News & Updates

Apatinib shows promise in recurrent, metastatic head-neck cancer

06 Nov 2022

In patients with recurrent or metastatic inoperable head and neck squamous cell carcinoma (HNSCC), treatment with the novel antiangiogenic agent apatinib appears to be effective, leading to high rates of disease control, a recent study has found.

Apatinib shows promise in recurrent, metastatic head-neck cancer

06 Nov 2022

Dulaglutide effective for T2DM in Asians

06 Nov 2022

Treatment with dulaglutide is both effective and safe in Asians with type 2 diabetes mellitus (T2DM), a recent meta-analysis has found.

Dulaglutide effective for T2DM in Asians

06 Nov 2022

Tuberculosis doubles risk of death in patients on ART

06 Nov 2022

Coinfection of tuberculosis (TB) among people with HIV initiating antiretroviral therapy (ART) aggravates the risk of death, a recent study has found.

Tuberculosis doubles risk of death in patients on ART

06 Nov 2022

First-line ART failure in kids common

05 Nov 2022

Failure of first-line antiretroviral therapy (ART) among kids is common, particularly young girls, according to a recent meta-analysis of studies from Ethiopia.

First-line ART failure in kids common

05 Nov 2022

Dextromethorphan offers no benefit for relieving pain during medication abortion

05 Nov 2022

Dextromethorphan, when used in addition to standard analgesics, falls short of reducing the pain experienced by women undergoing medication abortion, according to a trial.

Dextromethorphan offers no benefit for relieving pain during medication abortion

05 Nov 2022

Foetoplacental factors predict hypertension in early childhood

05 Nov 2022

Foetal growth deceleration and high foetoplacental vascular resistance both contribute to an increased risk of prehypertension and hypertension in children, a study has found.

Foetoplacental factors predict hypertension in early childhood

05 Nov 2022

Slow disease progression seen in people with NAFLD

05 Nov 2022

A 23-year longitudinal follow-up in a population-based cohort has shown a slowly progressive trend in nonalcoholic fatty liver disease (NAFLD), with liver-related outcomes affecting only a small number of people, reports a recent study.

Slow disease progression seen in people with NAFLD

05 Nov 2022

One in three Crohn’s disease patients undergo ustekinumab dose intensification

05 Nov 2022

Intensifying the dose of ustekinumab to 4- or 6-weekly is a common recourse among Crohn’s disease (CD) patients, a recent study has found. Patients who had failed prior therapies are more likely to see such intensification.

One in three Crohn’s disease patients undergo ustekinumab dose intensification

05 Nov 2022

Lidocaine outperforms amiodarone for in-hospital cardiac arrest

05 Nov 2022

In the treatment of adult patients with in-hospital cardiac arrest, lidocaine appears to result in more favourable survival and neurological outcomes as compared with amiodarone, a study has shown.

Lidocaine outperforms amiodarone for in-hospital cardiac arrest

05 Nov 2022

ICD therapy feasible in vasospastic angina after resuscitation

05 Nov 2022

Using implantable cardioverter defibrillator (ICD) as a secondary prophylaxis is feasible in patients resuscitated from sudden cardiac arrest (SCA), leading to similar long-term outcomes in those with vasospastic angina (VSA) or other cardiac diseases, a recent study has found.

ICD therapy feasible in vasospastic angina after resuscitation

05 Nov 2022

News & Updates

Filter by Specialty:

Specialty:

Apatinib shows promise in recurrent, metastatic head-neck cancer

Apatinib shows promise in recurrent, metastatic head-neck cancer

Dulaglutide effective for T2DM in Asians

Dulaglutide effective for T2DM in Asians

Tuberculosis doubles risk of death in patients on ART

Tuberculosis doubles risk of death in patients on ART

First-line ART failure in kids common

First-line ART failure in kids common

Dextromethorphan offers no benefit for relieving pain during medication abortion

Dextromethorphan offers no benefit for relieving pain during medication abortion

Foetoplacental factors predict hypertension in early childhood

Foetoplacental factors predict hypertension in early childhood

Slow disease progression seen in people with NAFLD

Slow disease progression seen in people with NAFLD

One in three Crohn’s disease patients undergo ustekinumab dose intensification

One in three Crohn’s disease patients undergo ustekinumab dose intensification

Lidocaine outperforms amiodarone for in-hospital cardiac arrest

Lidocaine outperforms amiodarone for in-hospital cardiac arrest

ICD therapy feasible in vasospastic angina after resuscitation

ICD therapy feasible in vasospastic angina after resuscitation